Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica

Postgraduate Medical Journal

Volumn 79, Issue 932, 2003, Pages 341-344

  Adedayo, Olayinka ^a   Grell, G ^a   Bellot, P ^b  

^a ROSS UNIVERSITY SCHOOL OF MEDICINE   (Dominica)

^b Department of Pathology ^*  (Dominica)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DOMINICA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RETROVIRUS; SCREENING; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DOMINICA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV SEROPOSITIVITY; HOSPITALIZATION; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED;

EID: 0037668268     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.932.341     Document Type: Article

References (29)

1. Poiesz BJ, Ruscetti FW, Gazder AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-19.
2. de The G, Bomford R. An HTLV-1 vaccine: why, how, for whom? AIDS Res Hum Retroviruses 1993;9:381-6.
3. Mueller N, Okayama A, Stuver S, et al. Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(suppl 1):S2-7.
4. Figueroa JP. Heterosexual transmission of HTLV-1; epidemiological aspects. W I Med J 1996;45:4-8.
5. Uchiyama T, Yodor J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematological features of 16 cases. Blood 1977;50:481-92.
6. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985;ii:407-10.
7. Osame M, Usuku K, Izumo S, et al. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986;i:1031-2.
8. Mochizuki M, Tajima K, Watanabe T, et al. Human T-lymphotropic virus type 1 uveitis. Br J Ophthalmol 1994;78:149-54.
9. la Grenade L, Hanchard B, Fletcher V, et al. Infective dermatitis of Jamaican children: a marker for HTLV-1 infection. Lancet 1990;336:1345-7.
10. Morgan O st C, Rodgers-Johnson P, Mora C, et al. HTLV-1 and polymyositis in Jamaica. Lancet 1989;ii:1184-7.
11. Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome. Lancet 1994;344:1116-19.
12. Barton EN, St C Morgan, Smikle MF, et al. Seroprevalence of HTLV-1 in chronic disease patients in Jamaica. Trans R Soc Trop Med Hyg 1994;88:410-11.
13. Sato K, Maruyama I, Maruyama Y, et al. Arthritis in patients infected with human T-lymphotropic virus type-1. Clinical and immuno-pathological features. Arthritis Rheum 1991;34:717-21.
14. Marsh BJ. Infections complications of human T-cell leukemia/lymphoma virus type 1 infection. Clin Infect Dis 1996;23:138-45.
15. Cleghorn FR, Manns R, Falk R, et al. Effect of human T-lymphotropic virus type-1 infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst 1995;87:1009-14.
16. Maloney EM, Cleghorn FR, Morgan OS, et al. Incidence of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retroviral 1998;17:167-70.
17. Uchiyama T. Human T-cell leukemia virus type 1 (HTLV-1) and human diseases. Annu Rev Immunol 1997;15:15-37.
18. Hanchard B. Adult T-cell leukemia/lymphoma in Jamaica 1986-1995. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S20-5.
19. Kamihira S, Yamada Y, Ikeda S, et al. Risk of adult T-cell leukemia developing in individuals with HTLV-1 infection. Leuk Lymphoma 1992;6:437-9.
20. Centers for Disease Control and Prevention and the USHS Working Group. Guidelines for counseling of persons infected with human T-lymphotropic virus type (HTLV-1) and type 11 (HTLV-1). Ann Intern Med 1993;118:448-54.
21. Brosset C, Hovette P, Raphenon G, et al. HTLV-1 and co-infections. Med Trop (Mars) 1991;51:399-406.
22. Neisson-Vernant C, Edouard A. Malignant strongyloidiasis and the HTLV-1 virus. Rev Pract 1990;40:2127-8.
23. Adedayo AO, Grell GAC, Bellot P. Fatal strongyloidiasis associated with human T-cell lymphotropic virus type-1 infection. Am J Trop Med Hyg 2001;65:650-1.
24. Mollison LC, Los T, Marning G. HTLV-1 and scabies an Australian aborigines (letter). Lancet 1993;341:1281-2.
25. Del Guidice P. Scabies in HTLV-1 seropositive patients (letter). J Am Acad Dermatol 1997;36:134-5.
26. Robinson RD, Murphy EL, Wilks RJ, et al. Gastrointestinal parasitic infection in healthy Jamaican carriers of HTLV-1. J Trop Med Hyg 1991;94:411-15.
27. Pierik LT, Murphy EL. The clinical significance of HTLV-1 and HTLV-11 infection in the AIDS epidemic. AIDS Clin Rev 1991: 39-57.
28. Matsumoto T, Miike T, Mizoguchi K, et al. Decreased serum levels of IgE and IgE binding factors in individuals infected with HTLV-1. Clin Exp Immunol 1990;81:207-11.
29. Newton RC, Limpuangthip P, Greenberg S, et al. Strongyloides stercoralis infection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am J Med 1992;92:202-8.